BioCentury
ARTICLE | Company News

Charles River, Inveresk Research Group Inc. deal

October 25, 2004 7:00 AM UTC

CRL completed its previously announced acquisition of IRGI, a CRO, in a stock and cash deal worth $1.5 billion based on CRL's Oct. 19 closing price of $48.79. IRGI shareholders will receive 0.48 share...